BioAge Labs, Inc. (BIOA) financial statements and ratios from SEC XBRL: revenue $8.99M (TTM), net margin -896.1%. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $8.99M |
| Net Margin | -896.1% |
| Price / Book | 1.16 |
| Price / Sales | 43.32 |
| FCF Yield | -33.5% |
| Altman Z-Score | 9.55 (safe) |
| Sector P/E (Healthcare) | 21.7 |
BIOA overview · BIOA earnings · BIOA KPIs · BIOA investor relations · BIOA ownership · BIOA peers · BIOA filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.